Circulating nucleosomes as potential markers to monitor COVID-19 disease progression

E Cavalier, J Guiot, K Lechner, A Dutsch… - Frontiers in Molecular …, 2021 - frontiersin.org
… elevated in COVID-19 patients, we tested two independent cohorts of COVID-19 positive
patients … in plasma of COVID-19 patients with a severe course of the disease relative to healthy …

COVID19 disease severity assessment using CNN model

E Irmak - IET image processing, 2021 - Wiley Online Library
COVID-19 disease severity score based on opacity degree and the lung involvement is
established from chest X-ray images of the COVID-19 … The COVID-19 lung disease severity score …

[PDF][PDF] Analytical review analysis for screening COVID-19 disease

PK Vaishnav, S Sharma, P Sharma - International Journal of Modern …, 2021 - ijmore.co.in
… pandemic caused by CORONA virus and declared as COVID-19 by world health … in
progress. Here in this paper analytical analysis is performed to find out the impact of COVID-19 in …

Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study

W Hou, W Zhang, R Jin, L Liang, B Xu, Z Hu - Infectious diseases, 2020 - Taylor & Francis
… for disease progression of cases with COVID-19. Based on the clinical types, the patients
were divided into a progression … performed to explore the risk factors for disease progression. …

Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease

M Li, W Guo, Y Dong, X Wang, D Dai, X Liu… - Frontiers in …, 2020 - frontiersin.org
… patients from Wuhan Union hospital, one of the designated hospitals for the treatment of
COVID-19, were included in this study along with 37 age-matched healthy volunteers. Patients’ …

A review on Promising vaccine development progress for COVID-19 disease

TM Belete - Vacunas, 2020 - Elsevier
… respiratory diseases are severe acute respiratory disease (SARS-… -CoV-2 that causes
COVID-19 disease emerged in China as a … According to Johns Hopkins’ COVID-19 global case …

Asymptomatic COVID19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2

YH Chan, SW Fong, CM Poh, G Carissimo… - EMBO molecular …, 2021 - embopress.org
… to ameliorate symptom progression in COVID19 patients and may also improve our
understanding of whether COVID19 vaccines offer protection against infection and transmission. …

Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers

Y Tjendra, AF Al Mana, AP Espejo… - … of pathology & …, 2020 - meridian.allenpress.com
COVID-19 disease. Significantly elevated white blood cell count; marked lymphopenia;
decreased CD3, CD4, or CD8 T-lymphocyte counts; high neutrophil count; thrombocytopenia; …

Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study Group

ALV Hobbs, N Turner, I Omer, MK Walker… - Infection Control & …, 2021 - cambridge.org
disease and death in hospitalized patients with COVID19 in … mortality and severe COVID-19
disease with mortality risk … Age was also an independent risk factor for severe disease, …

Internet search patterns reveal clinical course of COVID-19 disease progression and pandemic spread across 32 countries

T Lu, BY Reis - NPJ digital medicine, 2021 - nature.com
… preceded increases in reported COVID-19 cases and deaths by an … disease progression.
Internet search patterns revealed a clear temporal pattern of disease progression for COVID-19